Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease — Stella

Home/Alzheimer Disease/

View on ClinicalTrials.gov

Recruiting

Back to Alzheimer Disease trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(2 sites)

United States

Mayo Clinic, Jacksonville, Florida

Mayo Clinic, Rochester, Minnesota

Key details

Phase

Post-approval study

Sponsor

Mayo Clinic

Collaborators

National Institute on Aging (NIA)

Enrollment target

~614 participants

Started

June 2019

Primary completion

May 2030

Age range

60 Years and older

Sex

Female only

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.